Skip to content. | Skip to navigation

European Coalition on Homeopathic & Anthroposophic Medicinal Products

Navigation

July & August 2015

News from the Board and Fields of Activity

Political affairs

  •  On 19 August, the Article 16.2 steering group met in Karlsruhe. They prepared the next steps of the project. For more information, please contact Christiaan Mol.
  •  On 09 July, a delegation from ECHAMP met Vytenis Andriukaitis, the Commissioner for Health and Food Safety. The delegation included the President and General Secretary of ECHAMP, Dr Harald Orth of DHU, Dr Monica Mennet-von Eiff from WELEDA, and Mrs Ineke Bos and Mr Josip Mejerzon, both from Mitela UAB in Lithuania. Our Lithuanian members joined the meeting as they knew the Commissioner from his period as Health Minister in Lithuania, during which the problem of homeopathic medicinal products with indications, which arose after Lithuania joined the EU, was solved.  Dr Andriukaitis was accompanied by Annika Nowak (Cabinet member) and Stefano Soro (Head of Unit ‘Medicinal products: quality, safety and efficacy’ in DG SANTE). The delegation addressed the specific characteristics of homeopathic and anthroposophic medicinal products and referred to the potential of these therapeutic approaches to effectively address current EU health priorities (e.g. chronic diseases and antibiotic resistance). They also provided a brief summary of activities undertaken in the field of availability with the previous Commissioners and the main results of ECHAMPs availability report; special emphasis was put on the surprising results in relation to demand for the products, in particular in the ‘new’ Member States of the EU. The Commissioner showed interest in being better informed about the concrete barriers and issues our industry is facing as well as feasible solutions.  ECHAMP will address the Commission this autumn with proposals and a plan to proceed forward.
  •   On 01 July, Members of the European Parliament met to discuss the availability of herbal, homeopathic and anthroposophic medicinal products in the EU (see News from ECHAMP). Experts from the CAM community outlined issues that limit availability of these medicinal products. As a follow up to the meeting, a cross-party group of MEPs, Sirpa Pietikäinen, Marian Harkin, Liisa Jaakonsaari, Alojz Peterle and Michèle Rivasi wrote to the European Health Commissioner, Vytenis Andriukaitis, urging him to issue a Communication addressing the problems highlighted by the Matrix report.

PR and communication

  • The Members’ advocacy pack has been upgraded: it now includes an EU timeline for homeopathic and anthroposophic medicinal products and an updated sheet on the contribution of homeopathic and anthroposophic medicine to major EU health challenges.
  • Work is underway on a new website. It will be mobile and tablet responsive and have an easier navigation. We expect to launch it before the end of this year.